Beijing Kawin Technology Share-Holding Co Ltd - Company Review
Beijing Kawin Technology Share-Holding Co Ltd - Company ReviewSummary
Beijing Kawin Technology Share-Holding Co Ltd (Kawin Technology) is a provider of healthcare solutions in the field of hepatology. The company manufactures bio-pharmaceuticals which include recombinant human interferon alfa 2b injection for the treatment of acute and chronic viral hepatitis, hairy cell leukemia and kidney carcinoma among others. It also offers contract research and manufacturing services for biological product development. Kawin Technology's technology transfer services include transfer of manufacturing processes and testing methods, conceptual design and enhancement of biopharmaceutical production lines and others. The company also provides academic promotion support which include promotion materials, KOL conference and post-marketing clinical data. Kawin Technology is headquartered in Beijing, China.
This comprehensive company report of Beijing Kawin Technology Share-Holding Co Ltd provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.